For this second installment of a six webinar series, join Dr. Mrugala of the Mayo Clinic, Arizona to hear how he is using live patient-specific tumor tissue to predict therapeutic response(s) in HGG patients before treatment initiation..
HGG patients have an extremely poor prognosis. Limited diagnostic tools are available to accurately predict treatment responses, leading to challenges in selecting effective therapeutic options. This interactive discussion will feature two real world clinical cases, presented by Dr. Maciej Mrugala of Mayo Clinic Phoenix, where a new functional precision oncology assay was used to direct therapy. There will also be time for attendees to participate in interactive Q&A.
This Functional Precision Medicine Webinar Series is powered by OncoLens. On a single, secure platform, OncoLens data science, informatics and advanced collaboration tools provide a first of a kind platform for targeted treatment planning and confident clinical decision making.
Maciej M Mrugala, MD, PhD, MPH
Professor of Medicine and Neurology
Comprehensive Neuro-Oncology Program
Mayo Clinic, Phoenix, Arizona
High Grade Glioma (HGG) Functional Precision Medicine Webinar Series
Chief Business Officer
Tessa DesRochers, PhD
Chief Scientific Officer